TY - JOUR
T1 - Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle
AU - Cockle, P. J.
AU - Gordon, S. V.
AU - Hewinson, R. G.
AU - Vordermeier, H. M.
PY - 2006/10/6
Y1 - 2006/10/6
N2 - In the search for improved tools with which to control bovine tuberculosis, the development of enhanced immunodiagnostic reagents is a high priority. Such reagents are required to improve the performance of tuberculin-based reagents and allow the discrimination of vaccinated cattle from those infected with Mycobacterium bovis. In this study, we identified the immunodominant, frequently recognized peptides from Rv3873, Rv3879c, Rv0288, and Rv3019c, which, together with peptides comprising the current lead diagnostic antigens, ESAT-6 and CFP-10, were formulated into a peptide cocktail. In a test of naturally infected cattle, this cocktail was significantly better than tuberculin was for identifying skin test-negative animals with confirmed bovine tuberculosis. In addition, the specificity of this cocktail was not compromised by Mycobacterium bovis BCG vaccination. In summary, our results prioritize this peptide-based, fully synthetic reagent for assessment in larger trials.
AB - In the search for improved tools with which to control bovine tuberculosis, the development of enhanced immunodiagnostic reagents is a high priority. Such reagents are required to improve the performance of tuberculin-based reagents and allow the discrimination of vaccinated cattle from those infected with Mycobacterium bovis. In this study, we identified the immunodominant, frequently recognized peptides from Rv3873, Rv3879c, Rv0288, and Rv3019c, which, together with peptides comprising the current lead diagnostic antigens, ESAT-6 and CFP-10, were formulated into a peptide cocktail. In a test of naturally infected cattle, this cocktail was significantly better than tuberculin was for identifying skin test-negative animals with confirmed bovine tuberculosis. In addition, the specificity of this cocktail was not compromised by Mycobacterium bovis BCG vaccination. In summary, our results prioritize this peptide-based, fully synthetic reagent for assessment in larger trials.
UR - http://www.scopus.com/inward/record.url?scp=33750344773&partnerID=8YFLogxK
U2 - 10.1128/CVI.00209-06
DO - 10.1128/CVI.00209-06
M3 - Article
C2 - 16943346
AN - SCOPUS:33750344773
SN - 1556-6811
VL - 13
SP - 1119
EP - 1124
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
IS - 10
ER -